Suppr超能文献

I型糖尿病肾病患者的多种脂蛋白异常

Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.

作者信息

Groop P H, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti G C, Taskinen M R

机构信息

Unit for Metabolic Medicine, Guy's Hospital, London, UK.

出版信息

Diabetes. 1996 Jul;45(7):974-9. doi: 10.2337/diab.45.7.974.

Abstract

The aim of this study was to characterize abnormalities of triglyceride-rich apolipoprotein (apo) B-containing lipoproteins in type I diabetic patients with elevated albumin excretion rates (AERs). Sixty-four patients (31 men, 33 women) with normoalbuminuria (AER <20 microg/min), 52 (35 men, 17 women) with microalbuminuria (AER 20-200 microg/min), and 37 (17 men, 20 women) with albuminuria (AER >200 microg/min) and 56 healthy control subjects matched for age and body weight were studied. The major finding was increased mass concentrations of the highly atherogenic intermediate-density lipoprotein fraction in patients with microalbuminuria (P < 0.05) and albuminuria (P < 0.05), compared with those with normoalbuminuria. Triglyceride, free cholesterol, cholesterol ester, and phospholipid concentrations in the VLDL, intermediate-density lipoprotein, and LDL (P < 0.05-0.01), as well as total cholesterol, total triglyceride, and apoB concentrations were higher in patients with renal disease than in those without. Notably, there were no differences between patients with microalbuminuria and albuminuria. Only minor compositional changes could be detected. Postheparin plasma lipoprotein lipase (LPL) activities were identical, but hepatic lipase activities were higher in microalbuminuric and albuminuric patients than in normoalbuminuric patients (P < 0.01). LPL activity and VLDL1, (Sf 60-400) (r = -0.528; P < 0.001) and VLDL2 (Sf 20-60) mass concentrations (r = -0.471; P < 0.001) were negatively related. In conclusion, in type I diabetic patients with early renal disease, there are multiple lipoprotein changes, which are potentially atherogenic and may contribute to the excess of macrovascular complications seen in such patients.

摘要

本研究旨在明确白蛋白排泄率(AER)升高的I型糖尿病患者中富含甘油三酯的载脂蛋白(apo)B脂蛋白异常情况。研究对象为64例(31例男性,33例女性)正常白蛋白尿(AER<20μg/min)患者、52例(35例男性,17例女性)微量白蛋白尿(AER 20 - 200μg/min)患者、37例(17例男性,20例女性)白蛋白尿(AER>200μg/min)患者以及56例年龄和体重匹配的健康对照者。主要发现为,与正常白蛋白尿患者相比,微量白蛋白尿患者(P<0.05)和白蛋白尿患者(P<0.05)中具有高度致动脉粥样硬化性的中密度脂蛋白部分的质量浓度升高。肾病患者的极低密度脂蛋白(VLDL)、中密度脂蛋白和低密度脂蛋白(LDL)中的甘油三酯、游离胆固醇、胆固醇酯和磷脂浓度(P<0.05 - 0.01),以及总胆固醇、总甘油三酯和apoB浓度均高于无肾病患者。值得注意的是,微量白蛋白尿患者和白蛋白尿患者之间无差异,仅检测到微小的成分变化。肝素后血浆脂蛋白脂肪酶(LPL)活性相同,但微量白蛋白尿和白蛋白尿患者的肝脂肪酶活性高于正常白蛋白尿患者(P<0.01)。LPL活性与VLDL1(Sf 60 - 400)(r = -0.528;P<0.001)和VLDL2(Sf 20 - 60)质量浓度(r = -0.471;P<0.001)呈负相关。总之,在患有早期肾病的I型糖尿病患者中,存在多种脂蛋白变化,这些变化具有潜在致动脉粥样硬化性,可能导致此类患者出现过多的大血管并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验